
An experimental drug may one day be a cure for eczema, a new trial suggests. The drug, rocatinlimab, is a monoclonal antibody that researchers found prevented the recurrence of the symptoms of the skin condition for up to 20 weeks after treatment was stopped. “Patients ask us in the clinic all the time, ‘Can I… read on > read on >